Influenza virus, human: two avenues for the new treatment
Casselyn, M.
Revue Medicale Suisse 5(194): 605
2009
ISSN/ISBN: 1660-9379 PMID: 19405281 Document Number: 13149
Document emailed within 1 workday
Related Documents
L'vov, D.K. 2006: Population interactions in biological system: influenza virus A--wild and domestic animals--human; reasons and consequences of introduction high pathogenic influenza virus A/H5N1 on Russian territory Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2006(3): 96-100Rukavishnikova, G.E.; Alekseeva, A.K. 1977: Influenza virus antigens in human leukocytes after oral administration of live tissue culture influenza a monovaccine Acta Virologica 21(5): 391-396
Reĭzin, F.N.; Chumakov, M.P.; Mart'ianova, L.I. 1982: Stabilization of the influenza virus by normal serum. Increase in the infectious activity of the influenza virus in chick embryos Voprosy Virusologii 27(5): 106-109
Higashihara, M.; Igarashi, Y.; Saito, Y. 1976: Recombinant influenza-virus vaccines. IV. Segregation of antigenic and some biological properties of Influenza virus neuraminidase by recombination Kitasato Archives of Experimental Medicine 49(3): 81-91
Chernetsov, I.V.; Slepushkin, A.N.; L'vov, D.K.; Braude, N.A.; Gavrilov, A.E. 1980: Isolation of influenza virus from Chlidonias nigra and serologic examination of the birds for antibodies to influenza virus Voprosy Virusologii 1: 35-40
Yanagita, M.; Kuwamura, Y.; Kinoshita, S.; Nakajima, T.; Tomizawa, S.; Ozawa, T. 2014: Mutations in the Neuraminidase Gene of the Epidemic Influenza Virus Strain Isolated in the 2012-2013 Season and Improvement of a PCR Assay for the Detection of Influenza Virus Rinsho byori. Japanese journal of clinical pathology 62(10): 937-941
Stelmakh, T.A.; Medvedeva, M.N.; Golubev, D.B. 1982: Analysis of specific interactions influenza virus and cells of different sensitivity. Note 2. Characteristics of influenza virus-host cell interaction in persistent infection Virologie 33(1): 47-51
Bender, A.; Amann, U.; Jäger, R.; Nain, M.; Gemsa, D. 1993: Effect of granulocyte/macrophage colony-stimulating factor on human monocytes infected with influenza a virus. Enhancement of virus replication, cytokine release, and cytotoxicity Journal of Immunology 151(10): 5416-5424
Chomik, M. 1986: Ultrastructure and some biological properties of influenza A virus. I. Alterations in the activity of surface antigens of influenza A virus by enzymes and infectious activity of such changed viruses Archivum Immunologiae et Therapiae Experimentalis 34(1): 49-57
Hackemann, M.M.; Denman, A.M.; Tyrrell, D.A. 1974: Inactivation of influenza virus by human lymphocytes Clinical and Experimental Immunology 16(4): 583-591
Petrov, N.A.; Netesov, S.V.; Blinov, V.M.; Vasilenko, S.K. 1986: Evolution of the hemagglutinin gene of human influenza a virus H3 subtype Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 11: 7-14
Efimov, S.V.; Oreshkov, A.B.; Mishchenko, B.S. 1990: Stabilization of suspensions of the influenza virus using human serum albumin Voprosy Virusologii 35(2): 160-162
Larson, H.E.; Blades, R. 1976: Impairment of human polymorphonuclear leucocyte function by influenza virus Lancet 1(7954): 283
Higashihara, M. 1975: Studies on genetic recombinants of influenza virus: fundamental studies on recombinant influenza-virus vaccines Kitasato Archives of Experimental Medicine 48(4): 183-188
Roux, P.; Fugon, L.; Winnock, M.; Salmon-Céron, D.; Lacombe, K.; Sogni, P.; Spire, B.; Dabis, F.ço.; Carrieri, M.P. 2012: Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users Addiction 107(1): 152-159
Cheng, A.C.; Dwyer, D.E.; Kotsimbos, A.Thomas.C.; Starr, M.; Korman, T.M.; Buttery, J.P.; Jenkins, C.R.; Krause, V.L.; Johnson, P.D.R. 2009: Summary of the Australasian Society for Infectious Diseases and the Thoracic Society of Australia and New Zealand guidelines: treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents Medical journal of Australia 191(3): 142-145
Meshkova, E.N.; Mentkevich, L.M. 1987: Formation of an acid-labile interferon induced in human leukocytes by the influenza virus Voprosy Virusologii 32(1): 96-99
Gou, Y.; Xie, J.; Wang, M. 2000: A strain of influenza a H9N2 virus repeatedly isolated from human population in China Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 14(3): 209-212
Huan, L-Fang.; Yao, L-Hong.; Chen, A-Jun.; Cheng, C-Sheng.; Jia, R-Qing.; Tian, Q.; Bo, H.; Guo, J-Qiang.; Wang, M.; Shu, Y-Long.; Zhang, Z-Qing. 2007: Construction and immunogenicity study of DNA vaccine expressing human H5N1 influenza virus hemagglutinin Bing du Xue Bao 23(5): 366-370
Zhirnov, O.P.; Vorob'eva, I.V.; Safonova, O.A.; Malyshev, N.A.; Schwalm, F.; Klenk, H.-D. 2013: Pathogenic effect of pandemic influenza virus H1N1 under replication in cultures of human cells Voprosy Virusologii 58(4): 20-28